1H and 13C NMR characterization of hemiamidal isoniazid-NAD(H) adducts as possible inhibitors of InhA reductase of Mycobacterium tuberculosis
- PMID: 12740851
- DOI: 10.1002/chem.200204637
1H and 13C NMR characterization of hemiamidal isoniazid-NAD(H) adducts as possible inhibitors of InhA reductase of Mycobacterium tuberculosis
Abstract
Isoniazid (INH) is easily oxidized with manganese(III) pyrophosphate, a chemical model of the KatG protein involved in activation of INH inside the bacteria Mycobacterium tuberculosis. Performed in the presence of NAD(+), this oxidation generates a family of isomeric INH-NAD(H) adducts, which have been shown to be effective inhibitors of InhA, an enzyme essential in mycolic acid biosynthesis. In this work, we fully characterized by (1)H and (13)C NMR spectroscopy four main species of INH-NAD(H) adducts that coexist in solution. Two of them are open diastereoisomers consisting of the covalent attachment of the isonicotinoyl radical at position four of the nicotinamide coenzyme. The other two result from a cyclization involving the amide group from the nicotinamide and the carbonyl group from the isonicotinoyl radical to give diastereoisomeric hemiamidals. Although an INH-NAD(H) adduct with a 4S configuration has been characterized within the active site of InhA from Xray crystallography and this bound adduct interpreted as an open form (Rozwarski et al., Science 1998, 279, 98-102), it is legitimate to raise the question about the effective active form(s), open or cyclic, of INH-NAD(H) adduct(s). Is there a single active form or are several forms able to inhibit the InhA activity with different levels of inhibitory potency?
Similar articles
-
1H and 13C NMR characterization of pyridinium-type isoniazid-NAD adducts as possible inhibitors of InhA reductase of Mycobacterium tuberculosis.Org Biomol Chem. 2005 Feb 21;3(4):670-3. doi: 10.1039/b417698g. Epub 2005 Jan 21. Org Biomol Chem. 2005. PMID: 15703806
-
Binding of the tautomeric forms of isoniazid-NAD adducts to the active site of the Mycobacterium tuberculosis enoyl-ACP reductase (InhA): a theoretical approach.J Mol Graph Model. 2008 Nov;27(4):536-45. doi: 10.1016/j.jmgm.2008.09.006. Epub 2008 Sep 17. J Mol Graph Model. 2008. PMID: 18955002
-
[The mechanism of action of isoniazid. A chemical model of activation].Ann Pharm Fr. 2001 Sep;59(5):331-7. Ann Pharm Fr. 2001. PMID: 11787427 French.
-
Recent progress in the identification and development of InhA direct inhibitors of Mycobacterium tuberculosis.Mini Rev Med Chem. 2010 Mar;10(3):181-92. doi: 10.2174/138955710791185064. Mini Rev Med Chem. 2010. PMID: 20408801 Review.
-
Mechanisms of action of isoniazid.Mol Microbiol. 2006 Dec;62(5):1220-7. doi: 10.1111/j.1365-2958.2006.05467.x. Epub 2006 Oct 27. Mol Microbiol. 2006. PMID: 17074073 Review.
Cited by
-
Isoniazid-resistance conferring mutations in Mycobacterium tuberculosis KatG: catalase, peroxidase, and INH-NADH adduct formation activities.Protein Sci. 2010 Mar;19(3):458-74. doi: 10.1002/pro.324. Protein Sci. 2010. PMID: 20054829 Free PMC article.
-
In vitro inhibition of the Mycobacterium tuberculosis beta-ketoacyl-acyl carrier protein reductase MabA by isoniazid.Antimicrob Agents Chemother. 2004 Jan;48(1):242-9. doi: 10.1128/AAC.48.1.242-249.2004. Antimicrob Agents Chemother. 2004. PMID: 14693546 Free PMC article.
-
Drug-resistant strains of Mycobacterium tuberculosis: cell envelope profiles and interactions with the host.Front Cell Infect Microbiol. 2023 Oct 27;13:1274175. doi: 10.3389/fcimb.2023.1274175. eCollection 2023. Front Cell Infect Microbiol. 2023. PMID: 38029252 Free PMC article. Review.
-
Design, synthesis and biological characterization of novel inhibitors of CD38.Org Biomol Chem. 2011 May 7;9(9):3246-57. doi: 10.1039/c0ob00768d. Epub 2011 Mar 23. Org Biomol Chem. 2011. PMID: 21431168 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources